The site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of PE rat anti-mouse CD267 on mouse spelenocytes. Unstimulated mouse splenocytes were pre-incubated with Mouse BD Fc Block™ purified anti-mouse CD16/CD32 mAb 2.4G2 (Cat. No. 553141). The cells were then stained with FITC anti-mouse CD19 (Cat. No. 553785) and PE anti-mouse CD267 antibody (Clone 8F10, Cat. No. 558410; right panel) or PE-conjugated rat IgG2a (Clone R35-95, Cat. No. 553930; left panel). Flow cytometry was performed and the dot plots were derived from the gated events based on light scattering characteristics of viable splenocytes. Flow cytometry was performed on a BD™ FACSCalibur flow cytometry instrument.
Flow cytometric analysis of PE rat anti-mouse CD267 on mouse spelenocytes. Unstimulated mouse splenocytes were pre-incubated with Mouse BD Fc Block™ purified anti-mouse CD16/CD32 mAb 2.4G2 (Cat. No. 553141). The cells were then stained with FITC anti-mouse CD19 (Cat. No. 553785) and PE anti-mouse CD267 antibody (Clone 8F10, Cat. No. 558410; right panel) or PE-conjugated rat IgG2a (Clone R35-95, Cat. No. 553930; left panel). Flow cytometry was performed and the dot plots were derived from the gated events based on light scattering characteristics of viable splenocytes. Flow cytometry was performed on a BD™ FACSCalibur flow cytometry instrument.
Flow cytometric analysis of PE rat anti-mouse CD267 on mouse spelenocytes. Unstimulated mouse splenocytes were pre-incubated with Mouse BD Fc Block™ purified anti-mouse CD16/CD32 mAb 2.4G2 (Cat. No. 553141). The cells were then stained with FITC anti-mouse CD19 (Cat. No. 553785) and PE anti-mouse CD267 antibody (Clone 8F10, Cat. No. 558410; right panel) or PE-conjugated rat IgG2a (Clone R35-95, Cat. No. 553930; left panel). Flow cytometry was performed and the dot plots were derived from the gated events based on light scattering characteristics of viable splenocytes. Flow cytometry was performed on a BD™ FACSCalibur flow cytometry instrument.
Flow cytometric analysis of PE rat anti-mouse CD267 on mouse spelenocytes. Unstimulated mouse splenocytes were pre-incubated with Mouse BD Fc Block™ purified anti-mouse CD16/CD32 mAb 2.4G2 (Cat. No. 553141). The cells were then stained with FITC anti-mouse CD19 (Cat. No. 553785) and PE anti-mouse CD267 antibody (Clone 8F10, Cat. No. 558410; right panel) or PE-conjugated rat IgG2a (Clone R35-95, Cat. No. 553930; left panel). Flow cytometry was performed and the dot plots were derived from the gated events based on light scattering characteristics of viable splenocytes. Flow cytometry was performed on a BD™ FACSCalibur flow cytometry instrument.
Flow cytometric analysis of PE rat anti-mouse CD267 on mouse spelenocytes. Unstimulated mouse splenocytes were pre-incubated with Mouse BD Fc Block™ purified anti-mouse CD16/CD32 mAb 2.4G2 (Cat. No. 553141). The cells were then stained with FITC anti-mouse CD19 (Cat. No. 553785) and PE anti-mouse CD267 antibody (Clone 8F10, Cat. No. 558410; right panel) or PE-conjugated rat IgG2a (Clone R35-95, Cat. No. 553930; left panel). Flow cytometry was performed and the dot plots were derived from the gated events based on light scattering characteristics of viable splenocytes. Flow cytometry was performed on a BD™ FACSCalibur flow cytometry instrument.
Flow cytometric analysis of PE rat anti-mouse CD267 on mouse spelenocytes. Unstimulated mouse splenocytes were pre-incubated with Mouse BD Fc Block™ purified anti-mouse CD16/CD32 mAb 2.4G2 (Cat. No. 553141). The cells were then stained with FITC anti-mouse CD19 (Cat. No. 553785) and PE anti-mouse CD267 antibody (Clone 8F10, Cat. No. 558410; right panel) or PE-conjugated rat IgG2a (Clone R35-95, Cat. No. 553930; left panel). Flow cytometry was performed and the dot plots were derived from the gated events based on light scattering characteristics of viable splenocytes. Flow cytometry was performed on a BD™ FACSCalibur flow cytometry instrument.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
For flow cytometry of cell suspensions from peripheral lymphoid tissues, it is recommended that the cells be pre-incubated with Mouse BD Fc Block™ purified anti-mouse CD16/CD32 mAb 2.4G2 (Cat. no.553141).
The 8F10 monoclonal antibody specifically recognizes CD267 which is also known as transmembrane activator and calcium-modulating and cyclophilin ligand interactor(transmembrane activator and CAML interactor or TACI). CD267 is encoded by Tnfrsf13b (tumor necrosis factor receptor superfamily member 13B). CD267 is a type III transmembrane protein receptor that binds to the ligands BAFF (BLyS), and APRIL. BAFF overproduction is associated with lupus erythematosus and Sjögren's disease, two systemic autoimmune diseases. CD267 is expressed most notably on maturing subsets of splenic B cells such as transition type 2 (T2) and marginal zone (MZ) B cells and also in activated T-cells. In CD267 deficient mice, B cell numbers are increased and mice develop autoimmune disorders suggesting that CD267 plays a role in B cell regulation.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.